Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Assay Kit / ADA/PK Assay Elisa Kit

Clesrovimab ELISA Kit

Catalog #:   KDV02804 Specific References (13) DATASHEET
Sample type: Plasma, Serum
Sensitivity: 33.12 ng/mL
Range: 78.125 - 5,000 ng/mL
Overview

Catalog No.

KDV02804

Detection method

Colorimetric

Sample type

Plasma, Serum

Assay type

Quantitative

Range

78.125 - 5,000 ng/mL

Sensitivity

33.12 ng/mL

Precision

CV<20%

Recovery

80-120%

Shipping

2-8 ℃

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Alternative Names

MK 1654, MK-1654, MK1654, RB1, CAS: 2429913-18-6

Data Image
References

Supporting Pediatric RSV Clinical Trials Through Close Epidemiological Surveillance During the SARS-CoV-2 Pandemic., PMID:40312764

Human iPS cell-derived respiratory organoids as a model for respiratory syncytial virus infection., PMID:40262853

Efficacy of monoclonal antibodies and maternal vaccination for prophylaxis of respiratory syncytial virus disease., PMID:40240559

Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus., PMID:39852814

The recent landscape of RSV vaccine research., PMID:39802673

A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants., PMID:39601265

Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150., PMID:39590882

Mind the (preterm) gap: inequality in the UK's current RSV immunisation approach will leave many preterm babies unprotected against RSV this winter., PMID:39379140

Systematic Review of the Efficacy and Safety of RSV-Specific Monoclonal Antibodies and Antivirals in Development., PMID:39209729

Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance., PMID:38588960

[Prevention of respiratory syncytial virus infection in infants. What has been done and where are we today?]., PMID:38329302

Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults., PMID:37976891

Development of mRNA vaccines against respiratory syncytial virus (RSV)., PMID:36280532

Datasheet

Document Download

Clesrovimab ELISA Kit.pdf

 

$ 1128
Product specifications
96 T 1128

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Clesrovimab ELISA Kit [KDV02804]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only